Article
The activity of catechol-O-methyltransferase (COMT) is not impaired by high doses of epigallocatechin-3-gallate (EGCG) in vivo.
European journal of pharmacology - 5 Oct 2014
Lorenz Mario, Paul Friedemann, Moobed Minoo, Baumann Gert, Zimmermann Benno F, Stangl Karl, Stangl Verena
Abstract excerpt
Catechol-O-methyltransferase (COMT) inactivates many endogenous and exogenous compounds by O-methylation. Therefore, it represents a major enzyme of the metabolic pathway with important biological functions in hormonal and drug metabolism. The tea catechin epigallocatechin-3-gallate (EGCG) is known to inhibit COMT enzymatic activity in vitro. Based on beneficial in vitro results, EGCG is extensively used in human...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
